1.Yang R., Zhang X., and Li F., Role of Phospholipids and Copolymersin Enhancing Stability and Controlling Degradation of Intravenous Lipid Emulsions, Colloids Surf., A, 436, 434-442, 2013.
2.Stafford R.E. and Dennis E.A., Lysophospholipids as Biosurfactants,Colloids Surf., 30, 47-64, 1987.
3.McIntosh T.J., Simon S.A., and Needham D., Structure and Cohesive Properties of Sphingomyelin/Cholesterol Bilayers, Biochemistry, 31, 2012-2020, 1992.
4.Rossi M., Bioactive Egg Compounds, Use of Lecithin and Lecithin Fractions, Springer, 229-239, 2007.
5.Jimenez-Rojo N., García-Arribas A.B., Sot J., Alonso A., and Goni F.M., Lipid Bilayers Containing Sphingomyelins and Ceramides of Varying N-acyl Lengths: A Glimpse into SphingolipidComplexity, Biochim. Biophys. Acta, Part B: Biomembr.,
1838, 456-464, 2014.
6.Henry J.V.L., Fryer P.J., Frith W.J., and Norton I.T., The Influenceof Phospholipids and Food Proteins on The Size and Stabilityof Model Submicron Emulsions, Food Hydrocolloids, 24, 66-71, 2010.
7.Cullis P.R., Hope M.J., and Tilcock C.P.S., Lipid Polymorphismand The Roles of Lipids in Membranes, Chem. Phys. Lipids, 40, 127-144, 1986.
8.Edwards K., Johnsson M., Karlsson G., and Silvander M., Effect of Polyethyleneglycol-Phospholipids on Aggregate Structure in Preparations of Small Unilamellar Liposomes, Biophys. J., 73, 258-266, 1997.9.
Filippov A., Munavirov B., and Antzutkin O.N., Phase Transition,Ordering and Lateral Diffusion in Phospholipid Bilayers in the Presence of Poly()ethylene oxide)(, Mendeleev Commun., 22, 250-251, 2012.
10.Papahadjopoulos D., Vail W., Jacobson K., and Poste G., CochleateLipid Cylinders: Formation by Fusion of Unilamellar Lipid Vesicles, Biochim. Biophys. Acta, 394, 483-491, 1975.
11.Taylor K.M. and Morris R.M., Thermal Analysis of Phase Transition Behavior in Liposomes, Thermochim. Acta, 248, 289-301, 1995.
12.Solier J.D., Galera-Cortés E., Sabaté R., and Estelrich J., Translational Diffusion in Charged Phospholipid Bilayer Membranes, Colloids Surf., A, 270–271, 88-92, 2005.
13.Grüll H. and Langereis S., Hyperthermia-Triggered Drug Delivery from Temperature-Sensitive Liposomes using MRI-guided High Intensity Focused Ultrasound, J. Controlled Release,161, 317-327, 2012.
14.Kepczynski M., Nawalany K., Kumorek M., Kobierska A., Jachimska B., and Nowakowska M., Which Physical and Structural Factors of Liposome Carriers Control Their Drug-Loading Efficiency, Chem. Phys. Lipids, 155, 7-15, 2008.
15.Ishida T., Harada M., Wang X.Y., and Kiwada H., Accelerated Blood Clearance of PEGylated Liposomes Following PrecedingLiposome Injection: Effects of Lipid Dose and PEG SurfaceDensity and Chain Length of the First-Dose Liposomes, J. Controlled Release, 105, 305-317, 2005.
16.Levant B., Crane J.F., and Carlson S.E., Subchronic AntipsychoticDrug Treatment does Not Alter Brain Phospholipid FattyAcid Composition in Rats, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 30, 728-732, 2006.
17.Kluza E., Yuin Yeo S., Schmid S., Schaft D.W.J., Boekhoven R.W., Schiffelers R.M., Storm G., Strijkers G.J., and Nicolay
K., Antitumor Activity of Liposomal Glucocorticoids: The Relevance of Liposome-Mediated Drug Delivery, Intratumoral
Localization and Systemic Activity, J. Controlled Release, 151, 10-17, 2011.
18.Bayati S., Galantini L., Knudsen K.D., and Schillen K., Complexesof PEO-PPO-PEO Triblock Copolymer P123 and Bile Salt Sodium Glycodeoxycholate in Aqueous Solution: A Small Angle X-ray and Neutron Scattering Investigation, Colloids
Surf., A, 504, 426-436, 2016.
19.Maitani Y., PEGylated Lipidic Systems with Prolonged CirculationLongevity for Drug Delivery in Cancer Therapeutics, J. Drug Delivery Sci. Technol., 21, 27-34, 2011.
20.Shelke S.S., Phytosomes- A New Herbal Drug Delivery System,Int. J. Res. Pharm. Biomed. Sci., 3, 1710-1715, 2012.
21.Zarif L., Graybill J.R., Perlin D., and Mannino R.J., Cochleates:New Lipid-Based Drug Delivery System, J. Liposome Res., 10, 523-538, 2000.
22.Syed U.M., Woo A.F., Plakogiannis F., Jin T., and Zhu H., Cochleates Bridged by Drug Molecules, Int. J. Pharm., 363, 118-125, 2008.
)